Subscribe

Rani Therapeutics Holdings, Inc. (RANI)

USD0.68 +0.03 (+4.24%)
US NASDAQ Healthcare Biotechnology
Address 2051 Ringwood Avenue 95131
San Jose, CA, US
CEO Talat Imran
IPO 2021-07-30
CIK 1856725 ISIN US7530181004

Explore sections of this company profile

Description

Rani Therapeutics Holdings, Inc. functions as a clinical-stage biopharmaceutical enterprise focused on revolutionizing the delivery of biologic therapies through oral administration. Its flagship innovation, the RaniPill capsule, aims to supplant conventional subcutaneous or intravenous injections of biologics with a more convenient oral dosing method. The company maintains a comprehensive portfolio of investigational treatments. Among these is RT-101, an octreotide, which has progressed beyond Phase I clinical trials for the management of neuroendocrine tumors and acromegaly. Another promising candidate is RT-105, an anti-TNF-alpha antibody designed to address psoriatic arthritis. Additionally, RT-102, a parathyroid hormone for osteoporosis, is currently advancing through preclinical studies. Other therapies under development include RT-109, a human growth hormone for treating growth hormone deficiency; RT-110, a parathyroid hormone aimed at hypoparathyroidism; and RT-106, a basal insulin formulated for type 2 diabetes. Established in 2012, the company's corporate base is located in San Jose, California.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD0.68 +0.03 (+4.24%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
882.0K
Beta
0.76
Float Shares
47.14M
Free Float %
72.2%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-2.70% +8.00% +12.92% -15.63% -44.33% -20.00% +54.29% -76.42% -90.18% -90.18% -90.18%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Analyst Consensus (7 ratings, all time) Buy
Price Targets & DCF
Current price
0.68
Low 9.00 +1,230.4%
Consensus 15.67 +2,216.3%
Median 10.00 +1,378.2%
High 28.00 +4,039.0%
DCF (Unlevered) 0.34 -49.1%
DCF (Levered) 0.16 -76.8%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 100% Bullish
Rating 2026-05 Change
Strong Buy 1 0
Buy 3 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Price Target Summary
Period # Analysts Avg Target
Last Month
Last Quarter
Last Year
All Time 3
15.67
+2,216.3%
Quality scores
Altman Z-Score
-2.57
Distress
Piotroski F-Score
4 / 9
Average
MOAT Score
1 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
  • Revenue growth Biotechnology: +1.6%
    +58.9% Q1'26: +893.0% (vs Q1'25)
  • EPS growth Biotechnology: +29.7%
    +57.1% Q1'26: +82.2% (vs Q1'25)
  • FCF margin FCF growth · Biotechnology: +16.2%
    -2,047.2% Q1'26: -381.3% (vs Q1'25)
  • EBIT margin Biotechnology: +0.0%
    -2,346.0% Q1'26: -488.2% (vs Q1'25)
  • ROIC Biotechnology: -16.1%
    Q1'26: +851.1% (vs Q1'25)
  • Share dilution Biotechnology: -3.4%
    +132.3% Q1'26: +438.3% (vs Q1'25)
  • Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×
    -0.12× Q1'26: -0.12× (vs Q1'25)
Valuation Multiples From To
DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.76) × ERP
WACC = 94% × Ke + 6% × Kd (67.0%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Intrinsic value (base): 0.34 Current price: 0.68
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2021
actual
Dec 2022
actual
Dec 2024
actual
Dec 2025
actual
Dec 2026
3 Rev. Ana.
3 EPS Ana.
Dec 2027
3 Rev. Ana.
3 EPS Ana.
Dec 2028
4 Rev. Ana.
3 EPS Ana.
Dec 2029
3 Rev. Ana.
1 EPS Ana.
Dec 2030
3 Rev. Ana.
1 EPS Ana.
Revenue
2.72M
est: 2.19M (+24.0%)
est: 92.9K (-100.0%)
1.03M
est: 1.20M (-14.3%)
1.63M
est: 5.19M (-68.6%)
4.50M
4.50M – 4.50M
-13.3% YoY
8.58M
8.58M – 8.58M
+90.6% YoY
16.27M
16.27M – 16.27M
+89.7% YoY
21.86M
21.86M – 21.86M
+34.4% YoY
92.57M
92.57M – 92.57M
+323.4% YoY
EBITDA
-52.08M
est: -438.3K (-11,781.9%)
-61.66M
est: -18.6K (-331,896.1%)
-50.52M
est: -240.0K (-20,951.3%)
-37.41M
est: -1.04M (-3,502.0%)
-900.0K
-900.0K – -900.0K
+13.3% YoY
-1.71M
-1.71M – -1.71M
-90.6% YoY
-3.25M
-3.25M – -3.25M
-89.7% YoY
-4.37M
-4.37M – -4.37M
-34.4% YoY
-18.51M
-18.51M – -18.51M
-323.4% YoY
EBIT
-52.58M
est: -438.3K (-11,895.2%)
-62.20M
est: -18.6K (-334,847.0%)
-51.55M
est: -240.0K (-21,379.7%)
-38.31M
est: -1.04M (-3,588.6%)
-900.0K
-900.0K – -900.0K
+13.3% YoY
-1.71M
-1.71M – -1.71M
-90.6% YoY
-3.25M
-3.25M – -3.25M
-89.7% YoY
-4.37M
-4.37M – -4.37M
-34.4% YoY
-18.51M
-18.51M – -18.51M
-323.4% YoY
Net Income
-8.33M
est: -44.85M (+81.4%)
-30.59M
est: -41.31M (+26.0%)
-30.02M
est: -81.82M (+63.3%)
-29.67M
est: -27.73M (-7.0%)
-13.06M
-16.33M – -9.80M
+52.9% YoY
-15.70M
-18.38M – -13.02M
-20.2% YoY
-17.88M
-21.46M – -14.31M
-13.9% YoY
-19.10M
-19.10M – -19.10M
-6.8% YoY
-7.69M
-7.69M – -7.69M
+59.7% YoY
SGA
27.83M
est: 20.29M (+37.2%)
26.84M
est: 859.5K (+3,023.4%)
23.95M
est: 11.43M (+109.5%)
19.74M
est: 49.46M (-60.1%)
42.86M
42.86M – 42.86M
-13.3% YoY
81.68M
81.68M – 81.68M
+90.6% YoY
154.94M
154.94M – 154.94M
+89.7% YoY
208.26M
208.26M – 208.26M
+34.4% YoY
881.76M
881.76M – 881.76M
+323.4% YoY
EPS
-0.42
est: -1.58 (+73.3%)
-1.28
est: -1.45 (+11.8%)
-1.05
est: -1.23 (+14.3%)
-0.45
est: -0.43 (-5.9%)
-0.20
-0.25 – -0.15
+53.5% YoY
-0.24
-0.28 – -0.20
-23.1% YoY
-0.26
-0.32 – -0.22
-6.5% YoY
-0.29
-0.29 – -0.29
-11.5% YoY
-0.12
-0.12 – -0.12
+59.7% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-13 C 2/5 3/5 1/5 1/5 3/5 1/5 1/5
2026-05-12 C 2/5 3/5 1/5 1/5 3/5 1/5 1/5
2026-05-11 C 2/5 3/5 1/5 1/5 3/5 1/5 1/5
2026-05-08 C 2/5 3/5 1/5 1/5 3/5 1/5 1/5
2026-05-07 C 2/5 3/5 1/5 1/5 3/5 1/5 1/5
2026-05-06 C 2/5 3/5 1/5 1/5 3/5 1/5 1/5
2026-05-05 C- 1/5 3/5 1/5 1/5 2/5 1/5 1/5
2026-05-04 C- 1/5 3/5 1/5 1/5 2/5 1/5 1/5
2026-05-01 C- 1/5 3/5 1/5 1/5 2/5 1/5 1/5
2026-04-30 C- 1/5 3/5 1/5 1/5 2/5 1/5 1/5
2026-04-29 C- 1/5 3/5 1/5 1/5 2/5 1/5 1/5
2026-04-28 C- 1/5 3/5 1/5 1/5 2/5 1/5 1/5
2026-04-27 C- 1/5 3/5 1/5 1/5 2/5 1/5 1/5
2026-04-24 C- 1/5 3/5 1/5 1/5 2/5 1/5 1/5
2026-04-23 C- 1/5 3/5 1/5 1/5 2/5 1/5 1/5
2026-04-22 C- 1/5 3/5 1/5 1/5 2/5 1/5 1/5
2026-04-21 C- 1/5 3/5 1/5 1/5 2/5 1/5 1/5
2026-04-20 C- 1/5 3/5 1/5 1/5 2/5 1/5 1/5
2026-04-17 C- 1/5 3/5 1/5 1/5 2/5 1/5 1/5
2026-04-16 C- 1/5 3/5 1/5 1/5 2/5 1/5 1/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
-33.03M
OE per share TTM
-0.99
Owner's Yield
-21.39%
Maintenance CapEx ratio
Maint CapEx / Avg PPE
574.0%

Ownership Overview

Ownership breakdown
At a glance
Institutional holders
20
Total invested
727.3K
Insider transactions (90d)
0
Beneficial owners (>5%)
13
Beneficial owners (>5%)
# Reporting person Amount owned % of class Sole voting Shared voting Sole dispositive Shared dispositive Type Citizenship Filing date SEC filing
1 InCube Labs, LLC 22.41M 44.30% 22.41M 22.41M IN 2021-08-23
2 Mir Imran 22.41M 44.30% 22.41M 22.41M IN 2021-08-23
3 Isidoro Quiroga Moreno 11.73M 62.61% 11.73M 11.73M 11.00 HC, IN 2021-08-09
4 South Cone Investments Limited Partnership 8.30M 28.20% 8.30M 8.30M 11.00 PN 2024-10-17
5 South Lake Management LLC 8.30M 28.20% 8.30M 8.30M 11.00 OO 2024-10-17
6 South Lake One LLC 8.30M 28.20% 8.30M 8.30M 11.00 OO 2024-10-17
7 Aequanimitas Limited Partnership 5.20M 26.39% 5.20M 5.20M 11.00 PN 2022-02-01
8 Isidoro Alfonso Quiroga Cortés 5.20M 26.39% 5.20M 5.20M 11.00 HC, IN 2022-02-01
9 Armistice Capital, LLC 2.57M 8.66% 2.57M IA, OO Delaware 2024-11-14
10 Steven Boyd 2.57M 8.66% 2.57M HC, IN Delaware 2024-11-14
11 InCube Venture Associates II, LLC 2.57M 11.50% 2.57M 2.57M OO Delaware 2022-02-14
12 InCube Ventures II, L.P. 2.57M 11.50% 2.57M 2.57M PN Delaware 2022-02-14
13 Rani Investment Corporation 87.9K 0.40% 87.9K 87.9K CO Delaware 2022-02-14

Institutional Activity (13F)

Institutional ownership trend From To
13F snapshot — 2026 Q1
Investors holding
20
-48 vs prev Q
New positions
2
Closed positions
46
Increased
8
Reduced
3
Put/Call ratio
0.00
Calls held
Puts held
Top institutional holders
# Investor Shares / Δ Mkt value / Δ Own% / Δ Weight% / Δ Avg px / Perf. Hold / Status
1 6.30M +6.3M (+100.0%) 8.51B +8.5B (+100.0%) 17.24% +17.240 pp 7.77% +7.768 pp USD1.35 +0.0% 1 qtrs NEW
2 RA CAPITAL MANAGEMENT, L.P. 8.50M +8.5M (+100.0%) 11.48M +11.5M (+100.0%) 23.26% +23.261 pp 0.12% +0.118 pp USD1.35 +0.0% 1 qtrs NEW
3 SAMSARA BIOCAPITAL, LLC 8.50M +8.5M (+100.0%) 11.48M +11.5M (+100.0%) 23.26% +23.261 pp 1.18% +1.184 pp USD1.35 +0.0% 1 qtrs NEW
4 AWM INVESTMENT COMPANY, INC. 6.50M +6.5M (+100.0%) 8.78M +8.8M (+100.0%) 17.79% +17.788 pp 0.85% +0.847 pp USD1.35 +0.0% 1 qtrs NEW
5 VANGUARD GROUP INC 5.11M +4.2M (+477.6%) 6.90M +6.5M (+1,459.5%) 13.98% +11.561 pp 0.00% +0.000 pp USD2.88 -53.1% 18 qtrs
6 LONGAEVA PARTNERS L.P. 2.11M +2.1M (+100.0%) 2.85M +2.9M (+100.0%) 5.78% +5.784 pp 0.24% +0.239 pp USD1.35 +0.0% 1 qtrs NEW
7 SIREN, L.L.C. 2.00M +2.0M (+100.0%) 2.70M +2.7M (+100.0%) 5.47% +5.473 pp 0.08% +0.081 pp USD1.35 +0.0% 1 qtrs NEW
8 JANE STREET GROUP, LLC 1.32M +1.3M (+100.0%) 1.78M +1.8M (+100.0%) 3.61% +3.612 pp 0.00% +0.000 pp USD1.35 +0.0% 1 qtrs NEW
9 GEODE CAPITAL MANAGEMENT, LLC 860.9K +564.0K (+190.0%) 1.16M +1.0M (+683.4%) 2.36% +1.544 pp 0.00% +0.000 pp USD2.81 -52.0% 18 qtrs
10 BLACKROCK, INC. 527.7K +407.5K (+338.9%) 712.4K +652.3K (+1,085.5%) 1.44% +1.115 pp 0.00% +0.000 pp USD1.36 -0.7% 6 qtrs
11 NAN FUNG GROUP HOLDINGS LTD 493.6K +— (+0.0%) 666.3K +419.6K (+170.1%) 1.35% +0.000 pp 0.60% +0.183 pp USD17.82 -92.4% 18 qtrs
12 683 CAPITAL MANAGEMENT, LLC 487.2K +487.2K (+100.0%) 657.7K +657.7K (+100.0%) 1.33% +1.333 pp 0.03% +0.029 pp USD1.35 +0.0% 1 qtrs NEW
13 STATE STREET CORP 387.0K +324.6K (+519.8%) 522.5K +491.3K (+1,574.2%) 1.06% +0.888 pp 0.00% +0.000 pp USD2.52 -46.4% 18 qtrs
14 SQUAREPOINT OPS LLC 344.4K +344.4K (+100.0%) 464.9K +464.9K (+100.0%) 0.94% +0.942 pp 0.00% +0.001 pp USD1.35 +0.0% 1 qtrs NEW
15 UNITED SERVICES AUTOMOBILE ASSOCIATION 302.7K +— (+0.0%) 408.7K +257.4K (+170.1%) 0.83% +0.000 pp 0.03% +0.015 pp USD13.50 -90.0% 16 qtrs
16 GOLDMAN SACHS GROUP INC 285.8K +285.8K (+100.0%) 385.9K +385.9K (+100.0%) 0.78% +0.782 pp 0.00% +0.000 pp USD1.35 +0.0% 1 qtrs NEW
17 KESTRA PRIVATE WEALTH SERVICES, LLC 254.8K +28.7K (+12.7%) 344.0K +231.0K (+204.4%) 0.70% +0.079 pp 0.00% +0.003 pp USD1.06 +27.4% 5 qtrs
18 CITADEL ADVISORS LLC 213.5K +213.5K (+100.0%) 288.2K +288.2K (+100.0%) 0.58% +0.584 pp 0.00% +0.000 pp USD1.35 +0.0% 8 qtrs
19 SUSQUEHANNA INTERNATIONAL GROUP, LLP 173.9K +173.9K (+100.0%) 234.8K +234.8K (+100.0%) 0.48% +0.476 pp 0.00% +0.000 pp USD1.35 +0.0% 1 qtrs NEW
20 NORTHERN TRUST CORP 170.5K +73.5K (+75.7%) 230.1K +181.7K (+374.7%) 0.47% +0.201 pp 0.00% +0.000 pp USD3.14 -57.0% 18 qtrs
21 MILLENNIUM MANAGEMENT LLC 163.3K +163.3K (+100.0%) 220.5K +220.5K (+100.0%) 0.45% +0.447 pp 0.00% +0.000 pp USD1.35 +0.0% 1 qtrs NEW
22 UBS GROUP AG 151.5K +82.4K (+119.2%) 204.6K +170.0K (+491.9%) 0.41% +0.226 pp 0.00% +0.000 pp USD1.38 -2.2% 18 qtrs
23 CWA ASSET MANAGEMENT GROUP, LLC 150.0K +— (+0.0%) 202.5K +127.5K (+170.1%) 0.41% +0.000 pp 0.01% +0.005 pp USD0.92 +46.7% 4 qtrs
24 QUBE RESEARCH & TECHNOLOGIES LTD 148.2K +148.2K (+100.0%) 200.1K +200.1K (+100.0%) 0.41% +0.406 pp 0.00% +0.000 pp USD1.35 +0.0% 1 qtrs NEW
25 BRIDGEWAY CAPITAL MANAGEMENT, LLC 114.5K +114.5K (+100.0%) 154.6K +154.6K (+100.0%) 0.31% +0.313 pp 0.00% +0.003 pp USD1.35 +0.0% 10 qtrs
26 FARALLON CAPITAL MANAGEMENT LLC 78.0K +78.0K (+100.0%) 105.3K +105.3K (+100.0%) 0.21% +0.214 pp 0.00% +0.001 pp USD1.35 +0.0% 1 qtrs NEW
27 OMERS ADMINISTRATION CORP 69.2K +69.2K (+100.0%) 93.4K +93.4K (+100.0%) 0.19% +0.189 pp 0.00% +0.001 pp USD1.35 +0.0% 1 qtrs NEW
28 KING LUTHER CAPITAL MANAGEMENT CORP 58.0K +— (+0.0%) 78.3K +49.3K (+170.1%) 0.16% +0.000 pp 0.00% +0.000 pp USD2.54 -46.9% 11 qtrs
29 CITIGROUP INC 53.1K +53.1K (+100.0%) 71.7K +71.7K (+100.0%) 0.15% +0.145 pp 0.00% +0.000 pp USD1.35 +0.0% 1 qtrs NEW
30 WELL DONE, LLC 52.0K +— (+0.0%) 70.2K +44.2K (+170.1%) 0.14% +0.000 pp 0.01% +0.006 pp USD0.51 +164.7% 3 qtrs
31 VIRTU FINANCIAL LLC 51.2K +51.2K (+100.0%) 69.0K +69.0K (+100.0%) 0.14% +0.140 pp 0.00% +0.003 pp USD1.35 +0.0% 1 qtrs NEW
32 JANNEY MONTGOMERY SCOTT LLC 49.2K +— (+0.0%) 66.0K +41.0K (+164.0%) 0.13% +0.000 pp 0.00% +0.000 pp USD0.94 +43.6% 5 qtrs
33 MOTCO 48.1K +— (+0.0%) 65.0K +40.9K (+170.1%) 0.13% +0.000 pp 0.01% +0.004 pp USD9.58 -85.9% 14 qtrs
34 LIGHTHOUSE INVESTMENT PARTNERS, LLC 42.8K +42.8K (+100.0%) 57.8K +57.8K (+100.0%) 0.12% +0.117 pp 0.00% +0.002 pp USD1.35 +0.0% 1 qtrs NEW
35 BANK OF AMERICA CORP /DE/ 36.6K +18.9K (+106.2%) 49.4K +40.6K (+457.9%) 0.10% +0.052 pp 0.00% +0.000 pp USD2.60 -48.1% 18 qtrs
36 TWO SIGMA SECURITIES, LLC 35.9K +35.9K (+100.0%) 48.4K +48.4K (+100.0%) 0.10% +0.098 pp 0.01% +0.007 pp USD1.35 +0.0% 1 qtrs NEW
37 JEFFERIES FINANCIAL GROUP INC. 29.9K +29.9K (+100.0%) 40.3K +40.3K (+100.0%) 0.08% +0.082 pp 0.00% +0.000 pp USD1.35 +0.0% 1 qtrs NEW
38 MORGAN STANLEY 28.7K +21.9K (+324.8%) 38.7K +35.3K (+1,047.5%) 0.08% +0.060 pp 0.00% +0.000 pp USD1.49 -9.4% 17 qtrs
39 PRIME CAPITAL INVESTMENT ADVISORS, LLC 27.2K +— (+0.0%) 36.7K +23.1K (+170.1%) 0.07% +0.000 pp 0.00% +0.000 pp USD2.53 -46.6% 13 qtrs
40 LAFAYETTE INVESTMENTS, INC. 23.0K +3.1K (+15.5%) 31.0K +21.1K (+212.0%) 0.06% +0.008 pp 0.01% +0.004 pp USD8.47 -84.1% 14 qtrs
41 ACT ADVISORS, LLC. 16.1K +1.3K (+8.5%) 21.7K +14.3K (+193.0%) 0.04% +0.003 pp 0.01% +0.006 pp USD0.57 +136.8% 2 qtrs
42 CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. 15.9K +15.9K (+100.0%) 21.5K +21.5K (+100.0%) 0.04% +0.044 pp 0.00% +0.002 pp USD1.35 +0.0% 1 qtrs NEW
43 BRONTE CAPITAL MANAGEMENT PTY LTD. 14.9K +14.9K (+100.0%) 20.1K +20.1K (+100.0%) 0.04% +0.041 pp 0.00% +0.002 pp USD1.35 +0.0% 1 qtrs NEW
44 BALYASNY ASSET MANAGEMENT L.P. 14.7K +14.7K (+100.0%) 19.8K +19.8K (+100.0%) 0.04% +0.040 pp 0.00% +0.000 pp USD1.35 +0.0% 1 qtrs NEW
45 FARTHER FINANCE ADVISORS, LLC 13.8K +13.8K (+100.0%) 18.6K +18.6K (+100.0%) 0.04% +0.038 pp 0.00% +0.000 pp USD1.35 +0.0% 1 qtrs NEW
46 SBI SECURITIES CO., LTD. 13.8K +1.2K (+9.2%) 18.6K +12.3K (+194.9%) 0.04% +0.003 pp 0.00% +0.000 pp USD1.05 +28.6% 5 qtrs
47 DISCIPLINED INVESTORS, L.L.C. 12.2K +12.2K (+100.0%) 16.5K +16.5K (+100.0%) 0.03% +0.033 pp 0.01% +0.011 pp USD1.35 +0.0% 1 qtrs NEW
48 SANCTUARY ADVISORS, LLC 12.0K +12.0K (+100.0%) 16.2K +16.2K (+100.0%) 0.03% +0.033 pp 0.00% +0.000 pp USD1.35 +0.0% 1 qtrs NEW
49 EWA, LLC 11.1K +11.1K (+100.0%) 15.0K +15.0K (+100.0%) 0.03% +0.030 pp 0.00% +0.004 pp USD1.35 +0.0% 1 qtrs NEW
50 CARY STREET PARTNERS FINANCIAL LLC 10.6K +10.6K (+100.0%) 14.2K +14.2K (+100.0%) 0.03% +0.029 pp 0.00% +0.000 pp USD1.35 +0.0% 1 qtrs NEW
51 CERITY PARTNERS LLC 10.0K +— (+0.0%) 13.5K +8.5K (+170.1%) 0.03% +0.000 pp 0.00% +0.000 pp USD2.16 -37.5% 6 qtrs
52 ISLAY CAPITAL MANAGEMENT, LLC 9.6K +— (+0.0%) 13.0K +8.2K (+170.1%) 0.03% +0.000 pp 0.01% +0.005 pp USD10.33 -86.9% 15 qtrs
53 BARCLAYS PLC 8.1K +8.1K (+100.0%) 10.9K +10.9K (+100.0%) 0.02% +0.022 pp 0.00% +0.000 pp USD1.35 +0.0% 1 qtrs NEW
54 JPMORGAN CHASE & CO 7.8K +7.7K (+10,912.7%) 10.6K +10.5K (+30,060.0%) 0.02% +0.021 pp 0.00% +0.000 pp USD1.37 -1.5% 17 qtrs
55 TOWER RESEARCH CAPITAL LLC (TRC) 7.7K +1.5K (+23.5%) 10.4K +7.3K (+233.5%) 0.02% +0.004 pp 0.00% +0.000 pp USD0.67 +101.5% 3 qtrs
56 MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. 4.7K +4.7K (+100.0%) 6.4K +6.4K (+100.0%) 0.01% +0.013 pp 0.00% +0.000 pp USD1.35 +0.0% 1 qtrs NEW
57 ALLWORTH FINANCIAL LP 3.1K +— (+0.0%) 4.2K +2.7K (+170.1%) 0.01% +0.000 pp 0.00% +0.000 pp USD5.90 -77.1% 13 qtrs
58 STATE OF WYOMING 2.1K +2.1K (+100.0%) 2.8K +2.8K (+100.0%) 0.01% +0.006 pp 0.00% +0.000 pp USD1.35 +0.0% 1 qtrs NEW
59 GF FUND MANAGEMENT CO. LTD. 1.9K +1.9K (+100.0%) 2.5K +2.5K (+100.0%) 0.01% +0.005 pp 0.00% +0.000 pp USD1.35 +0.0% 1 qtrs NEW
60 BNP PARIBAS ARBITRAGE, SNC 1.6K +1.6K (+100.0%) 2.2K +2.2K (+100.0%) 0.00% +0.004 pp 0.00% +0.000 pp USD1.35 +0.0% 1 qtrs NEW
61 ADVISOR GROUP HOLDINGS, INC. 1.0K +— (+0.0%) 1.4K +860.0 (+175.5%) 0.00% +0.000 pp 0.00% +0.000 pp USD1.28 +5.5% 5 qtrs
62 JONES FINANCIAL COMPANIES LLLP 1.0K +1.0K (+100.0%) 1.4K +1.4K (+100.0%) 0.00% +0.003 pp 0.00% +0.000 pp USD1.35 +0.0% 1 qtrs NEW
63 ELYXIUM WEALTH, LLC 760.00 +760.0 (+100.0%) 1.0K +1.0K (+100.0%) 0.00% +0.002 pp 0.00% +0.000 pp USD1.35 +0.0% 1 qtrs NEW
64 CHOREO, LLC -11.8K (-100.0%) -5.9K (-100.0%) 0.00% -0.032 pp 0.00% 0.000 pp USD 5 qtrs SOLD
65 HRT FINANCIAL LP -113.2K (-100.0%) -56.0K (-100.0%) 0.00% -0.310 pp 0.00% 0.000 pp USD 2 qtrs SOLD
66 RENAISSANCE TECHNOLOGIES LLC -24.9K (-100.0%) -12.4K (-100.0%) 0.00% -0.068 pp 0.00% +0.000 pp USD 2 qtrs SOLD
67 INSIGNEO ADVISORY SERVICES, LLC -47.5K (-100.0%) -23.7K (-100.0%) 0.00% -0.130 pp 0.00% -0.002 pp USD 5 qtrs SOLD
68 EVERSOURCE WEALTH ADVISORS, LLC -980.0 (-100.0%) -490.0 (-100.0%) 0.00% -0.003 pp 0.00% +0.000 pp USD 2 qtrs SOLD
69 XTX TOPCO LTD -44.1K (-100.0%) -22.0K (-100.0%) 0.00% -0.121 pp 0.00% -0.001 pp USD 5 qtrs SOLD
70 BROWN ADVISORY INC -32.9K (-100.0%) -16.4K (-100.0%) 0.00% -0.090 pp 0.00% +0.000 pp USD 13 qtrs SOLD
Ownership breakdown by holder

ETF Ownership

Top ETFs holding this stock Held by 16 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 Invesco Nasdaq Biotechnology ETF IBBQ 0.01% 4.0K 0.19%
2 Invesco NASDAQ Biotech UCITS ETF SBIO.L 0.01% 24.4K 0.40%
3 iShares Nasdaq US Biotechnology UCITS ETF BTEE.L 0.00% 3.2K 0.35%
4 iShares Nasdaq US Biotechnology UCITS ETF BTEC.L 0.00% 47.7K 0.35%
5 ProShares Ultra Nasdaq Biotechnology BIB 0.00% 2.6K 1.19%
6 Vanguard Extended Market ETF VXF 0.00% 775.9K 0.05%
7 Vanguard U.S. Total Market Index ETF (CAD-hedged) VUS.TO 0.00% 1.5K 0.17%
8 Vanguard U.S. Total Market Shares Index ETF VTS.AX 0.00% 7.5K 0.03%
9 Vanguard U.S. Total Market Index ETF VUN.TO 0.00% 20.5K 0.17%
10 Vanguard Total Stock Market ETF VTI 0.00% 3.50M 0.03%

Insider Activity

Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Ratio by volume
0.00
Bearish
Buys
0
Sells
2
Shares acquired
Shares disposed
5.92M
Cash buys
Cash sales
2.00
Net activity
-5,923,000
Insider buys vs sells (history) From To
Recent insider transactions From To
Date Person Role Transaction A/D Security Shares Price Value Owned after D/I Filing
2026-03-18 Javadi Alireza Officer Class A Common Stock 0 0.00 10,075 D
2025-10-23 IMRAN MIR A Director / 10% Owner P-Purchase A Warrant to Purchase Class A Common Stock 2,083,334 0.48 1.00M 2,083,334 D
2025-10-23 Bassan Abraham 0 0.00 0
2025-10-23 Bailey Vasudev Jaiprakash 0 0.00 0
2025-10-21 South Cone Investments Limited Partnership 10% Owner S-Sale D Class A Common Stock 4,000,000 2.77 11.07M 2,379,194 I
2025-10-20 South Cone Investments Limited Partnership 10% Owner S-Sale D Class A Common Stock 1,923,000 2.41 4.64M 6,379,194 I
2025-08-01 McKinley Kate Officer A-Award A Employee Stock Option (Right to Buy) 120,000 0.53 63.4K 120,000 D
2025-05-28 Rometty Lisa Ann Director A-Award A Director Stock Option (Right to Buy) 50,000 0.62 31.0K 50,000 D
2025-05-28 Nanavaty Maulik Director A-Award A Director Stock Option (Right to Buy) 50,000 0.62 31.0K 50,000 D
2025-05-28 IMRAN MIR A Director A-Award A Director Stock Option (Right to Buy) 50,000 0.62 31.0K 50,000 D
2025-05-28 Farquharson Andrew Director A-Award A Director Stock Option (Right to Buy) 50,000 0.62 31.0K 50,000 D
2025-05-28 BUTEL JEAN LUC Director A-Award A Director Stock Option (Right to Buy) 50,000 0.62 31.0K 50,000 D
2025-05-28 Ausiello Dennis A Director A-Award A Director Stock Option (Right to Buy) 50,000 0.62 31.0K 50,000 D
2025-05-23 Sanford Svai S Officer A-Award A Stock Option (Right to Buy) 325,000 0.62 200.5K 325,000 D
2025-05-23 McKinley Kate Officer A-Award A Stock Option (Right to Buy) 325,000 0.62 200.5K 325,000 D
2025-05-23 Imran Talat Director / Officer A-Award A Stock Option (Right to Buy) 1,053,000 0.62 649.5K 1,053,000 D
2025-05-23 Hashim Mir Officer A-Award A Stock Option (Right to Buy) 325,000 0.62 200.5K 325,000 D
2024-12-16 Rometty Lisa Ann Director D-Return D Stock Option (Right to Buy) 17,708 2.84 50.3K 0 D
2024-12-16 Nanavaty Maulik Director D-Return D Stock Option (Right to Buy) 15,423 2.84 43.8K 0 D
2024-12-16 IMRAN MIR A Director D-Return D Stock Option (Right to Buy) 101,276 2.84 287.6K 0 D
2024-12-16 Farquharson Andrew Director D-Return D Stock Option (Right to Buy) 101,276 2.84 287.6K 0 D
2024-12-16 DEBUONO LAUREEN Director A-Award A Stock Option (Right to Buy) 18,875 9.44 178.2K 135,896 D
2024-12-16 BUTEL JEAN LUC Director D-Return D Stock Option (Right to Buy) 18,875 2.84 53.6K 0 D
2024-12-16 Ausiello Dennis A Director D-Return D Stock Option (Right to Buy) 15,423 2.84 43.8K 0 D
2024-12-13 McKinley Kate Officer P-Purchase A Class A Common Stock 17,960 1.67 30.0K 17,960 D
2024-12-09 Imran Talat Director / Officer P-Purchase A Class A Common Stock 10,296 1.94 20.0K 494,751 D
2024-10-15 South Cone Investments Limited Partnership 10% Owner S-Sale D Class A Common Stock 3,305,622 2.55 8.44M 8,825,932 I
2024-05-29 Rometty Lisa Ann Director A-Award A Stock Option (Right to Buy) 50,000 5.00 250.0K 50,000
2024-05-29 Nanavaty Maulik Director A-Award A Stock Option (Right to Buy) 50,000 5.00 250.0K 50,000
2024-05-29 IMRAN MIR A Director A-Award A Stock Option (Right to Buy) 50,000 5.00 250.0K 50,000
2024-05-29 Farquharson Andrew Director A-Award A Stock Option (Right to Buy) 50,000 5.00 250.0K 50,000
2024-05-29 DEBUONO LAUREEN Director A-Award A Stock Option (Right to Buy) 50,000 5.00 250.0K 50,000
2024-05-29 BUTEL JEAN LUC Director A-Award A Stock Option (Right to Buy) 50,000 5.00 250.0K 50,000
2024-05-29 Ausiello Dennis A Director A-Award A Stock Option (Right to Buy) 50,000 5.00 250.0K 50,000
2024-03-21 Sanford Svai S Officer A-Award A Stock Option (Right to Buy) 323,500 3.60 1.16M 323,500
2024-03-21 McKinley Kate Officer A-Award A Stock Option (Right to Buy) 323,500 3.60 1.16M 323,500
2024-03-21 Imran Talat Director / Officer A-Award A Stock Option (Right to Buy) 1,085,000 3.60 3.91M 1,085,000
2024-03-21 Hashim Mir Officer A-Award A Stock Option (Right to Buy) 323,500 3.60 1.16M 323,500
2024-03-21 Groen Eric Officer A-Award A Stock Option (Right to Buy) 323,500 3.60 1.16M 323,500
2023-12-16 Sanford Svai S Officer A-Award A Stock Option (Right to Buy) 171,500 2.84 487.1K 171,500
2023-12-16 Rometty Lisa Ann Director A-Award A Stock Option (Right to Buy) 101,276 2.84 287.6K 101,276
2023-12-16 Nanavaty Maulik Director A-Award A Stock Option (Right to Buy) 101,276 2.84 287.6K 101,276
2023-12-16 McKinley Kate Officer A-Award A Stock Option (Right to Buy) 250,000 2.84 710.0K 250,000
2023-12-16 Imran Talat Director / Officer A-Award A Stock Option (Right to Buy) 479,667 2.84 1.36M 479,667
2023-12-16 IMRAN MIR A Director A-Award A Stock Option (Right to Buy) 101,276 2.84 287.6K 101,276
2023-12-16 Hashim Mir Officer D-Return D Stock Option (Right to Buy) 171,500 5.44 933.0K 34,300
2023-12-16 Groen Eric Officer A-Award A Stock Option (Right to Buy) 171,500 2.84 487.1K 171,500
2023-12-16 Farquharson Andrew Director A-Award A Stock Option (Right to Buy) 101,276 2.84 287.6K 101,276
2023-12-16 DEBUONO LAUREEN Director D-Return D Stock Option (Right to Buy) 18,875 9.44 178.2K 117,021
2023-12-16 BUTEL JEAN LUC Director A-Award A Stock Option (Right to Buy) 18,875 2.84 53.6K 18,875
2023-12-16 Ausiello Dennis A Director A-Award A Stock Option (Right to Buy) 101,276 2.84 287.6K 101,276
2023-12-06 Imran Talat Director / Officer P-Purchase A Class A Common Stock 10,000 2.27 22.7K 484,455
2023-12-04 Imran Talat Director / Officer P-Purchase A Class A Common Stock 5,000 2.57 12.9K 474,455
2023-11-29 Imran Talat Director / Officer P-Purchase A Class A Common Stock 20,000 2.05 41.0K 469,455
2023-11-24 South Cone Investments Limited Partnership 10% Owner P-Purchase A Class A Common Stock 5,265,165 2.01 10.58M 12,131,554
2023-11-24 Quiroga Cortes Isidoro Alfonso 10% Owner S-Sale D Class A Common Stock 5,265,165 2.01 10.58M 8,400
2023-11-17 BUTEL JEAN LUC Director P-Purchase A Class A Common Stock 50,500 2.03 102.5K 50,500
2023-11-16 Nanavaty Maulik Director P-Purchase A Class A Common Stock 500 1.98 990.00 500
2023-11-07 Imran Talat Director / Officer P-Purchase A Class A Common Stock 2,500 1.98 5.0K 446,955
2023-08-07 McKinley Kate Officer 0 0.00 0
2023-05-25 Rometty Lisa Ann Director A-Award A Stock Option (Right to Buy) 101,276 4.11 416.2K 101,276
2023-05-25 Nanavaty Maulik Director A-Award A Stock Option (Right to Buy) 101,276 4.11 416.2K 101,276
2023-05-25 IMRAN MIR A Director A-Award A Stock Option (Right to Buy) 101,276 4.11 416.2K 101,276
2023-05-25 Farquharson Andrew Director A-Award A Stock Option (Right to Buy) 101,276 4.11 416.2K 101,276
2023-05-25 DEBUONO LAUREEN Director A-Award A Stock Option (Right to Buy) 101,276 4.11 416.2K 101,276
2023-05-25 BUTEL JEAN LUC Director A-Award A Stock Option (Right to Buy) 101,276 4.11 416.2K 101,276
2023-05-25 Ausiello Dennis A Director A-Award A Stock Option (Right to Buy) 101,276 4.11 416.2K 101,276
2023-05-22 McKinley Kate Officer A-Award A Stock Option (Right to Buy) 250,000 4.13 1.03M 250,000
2023-05-12 South Cone Investments Limited Partnership 10% Owner P-Purchase A Class A Common Stock 2,645 3.98 10.5K 6,866,389
2023-05-11 South Cone Investments Limited Partnership 10% Owner P-Purchase A Class A Common Stock 2,610 3.87 10.1K 6,863,744
2023-05-08 South Cone Investments Limited Partnership 10% Owner P-Purchase A Class A Common Stock 4,420 4.46 19.7K 6,861,134
2023-05-03 South Cone Investments Limited Partnership 10% Owner P-Purchase A Class A Common Stock 2,040 4.81 9.8K 6,856,714
2023-04-28 South Cone Investments Limited Partnership 10% Owner P-Purchase A Class A Common Stock 2,173 4.71 10.2K 6,854,674
2023-04-25 South Cone Investments Limited Partnership 10% Owner P-Purchase A Class A Common Stock 4,423 4.51 20.0K 6,852,501
2023-04-24 South Cone Investments Limited Partnership 10% Owner P-Purchase A Class A Common Stock 4,280 4.67 20.0K 6,848,078
2023-04-21 South Cone Investments Limited Partnership 10% Owner P-Purchase A Class A Common Stock 4,100 4.93 20.2K 6,843,798
2023-04-20 South Cone Investments Limited Partnership 10% Owner P-Purchase A Class A Common Stock 1,850 5.32 9.9K 6,839,698
2023-04-18 South Cone Investments Limited Partnership 10% Owner P-Purchase A Class A Common Stock 1,850 5.37 9.9K 6,837,848
2023-04-14 South Cone Investments Limited Partnership 10% Owner P-Purchase A Class A Common Stock 1,901 5.27 10.0K 6,835,998
2023-04-13 South Cone Investments Limited Partnership 10% Owner P-Purchase A Class A Common Stock 890 5.47 4.9K 6,834,097
2023-04-12 South Cone Investments Limited Partnership 10% Owner P-Purchase A Class A Common Stock 3,577 5.48 19.6K 6,833,207
2023-04-11 South Cone Investments Limited Partnership 10% Owner P-Purchase A Class A Common Stock 1,765 5.58 9.8K 6,829,630
2023-04-10 South Cone Investments Limited Partnership 10% Owner P-Purchase A Class A Common Stock 1,923 5.07 9.7K 6,827,865
2023-04-06 South Cone Investments Limited Partnership 10% Owner P-Purchase A Class A Common Stock 7,551 5.14 38.8K 6,825,942
2023-04-05 South Cone Investments Limited Partnership 10% Owner P-Purchase A Class A Common Stock 7,280 5.49 39.9K 6,818,391
2023-04-04 South Cone Investments Limited Partnership 10% Owner P-Purchase A Class A Common Stock 4,416 5.49 24.2K 6,811,111
2023-04-03 South Cone Investments Limited Partnership 10% Owner P-Purchase A Class A Common Stock 3,587 5.23 18.7K 6,806,695
2023-03-31 South Cone Investments Limited Partnership 10% Owner P-Purchase A Class A Common Stock 751 5.05 3.8K 6,803,108
2023-03-30 South Cone Investments Limited Partnership 10% Owner P-Purchase A Class A Common Stock 12,230 4.79 58.6K 6,802,357
2023-03-28 South Cone Investments Limited Partnership 10% Owner P-Purchase A Class A Common Stock 3,510 5.49 19.3K 6,790,127
2023-03-27 Sanford Svai S A-Award A Class A Common Stock 139,000 0.00 258,597
2023-03-27 Imran Talat A-Award A Stock Option (Right to Buy) 575,600 5.44 3.13M 575,600
2023-03-27 Hashim Mir A-Award A Class A Common Stock 139,000 0.00 273,265
2023-03-27 Groen Eric A-Award A Class A Common Stock 139,000 0.00 163,216
2023-03-22 Sanford Svai S Officer F-InKind D Class A Common Stock 3,355 5.95 20.0K 119,597
2023-03-22 Imran Talat Director / Officer F-InKind D Class A Common Stock 7,988 5.95 47.5K 90,945
2023-03-22 Hashim Mir Officer F-InKind D Class A Common Stock 4,201 5.95 25.0K 134,265
2023-03-22 Groen Eric Officer F-InKind D Class A Common Stock 2,498 5.95 14.9K 24,216
2023-03-21 South Cone Investments Limited Partnership 10% Owner P-Purchase A Class A Common Stock 3,230 6.08 19.6K 6,786,617
2023-03-20 South Cone Investments Limited Partnership 10% Owner P-Purchase A Class A Common Stock 532 6.29 3.3K 6,783,387
2023-03-17 South Cone Investments Limited Partnership 10% Owner P-Purchase A Class A Common Stock 2,980 6.19 18.4K 6,782,855
2023-03-16 South Cone Investments Limited Partnership 10% Owner P-Purchase A Class A Common Stock 1,325 6.07 8.0K 6,779,875
2023-03-13 South Cone Investments Limited Partnership 10% Owner P-Purchase A Class A Common Stock 2,463 6.14 15.1K 6,778,550
2023-03-09 South Cone Investments Limited Partnership 10% Owner P-Purchase A Class A Common Stock 3,730 6.56 24.5K 6,776,087
2023-03-08 South Cone Investments Limited Partnership 10% Owner P-Purchase A Class A Common Stock 1,702 6.58 11.2K 6,772,357
2023-03-06 South Cone Investments Limited Partnership 10% Owner P-Purchase A Class A Common Stock 1,100 6.39 7.0K 6,770,655
2023-03-02 South Cone Investments Limited Partnership 10% Owner P-Purchase A Class A Common Stock 3,900 6.31 24.6K 6,769,555
2023-02-28 South Cone Investments Limited Partnership 10% Owner P-Purchase A Class A Common Stock 711 6.30 4.5K 6,765,655
2023-02-27 South Cone Investments Limited Partnership 10% Owner P-Purchase A Class A Common Stock 3,541 6.30 22.3K 6,764,944
2023-02-24 South Cone Investments Limited Partnership 10% Owner P-Purchase A Class A Common Stock 5,451 6.09 33.2K 6,761,403
2023-02-22 South Cone Investments Limited Partnership 10% Owner P-Purchase A Class A Common Stock 1,000 6.10 6.1K 6,755,952
2023-02-21 South Cone Investments Limited Partnership 10% Owner P-Purchase A Class A Common Stock 3,080 5.94 18.3K 6,754,952
2023-02-17 South Cone Investments Limited Partnership 10% Owner P-Purchase A Class A Common Stock 8,468 5.88 49.8K 6,751,872
2023-02-16 South Cone Investments Limited Partnership 10% Owner P-Purchase A Class A Common Stock 9,500 5.49 52.1K 6,743,404
2023-02-15 South Cone Investments Limited Partnership 10% Owner P-Purchase A Class A Common Stock 10,000 5.20 52.0K 6,733,904
2023-02-14 South Cone Investments Limited Partnership 10% Owner P-Purchase A Class A Common Stock 9,250 5.25 48.6K 6,723,904
2022-12-30 South Cone Investments Limited Partnership Director P-Purchase A Class A Common Stock 8,600 5.98 51.5K 6,714,654
2022-12-30 Quiroga Cortes Isidoro Alfonso Director P-Purchase A Class A Common Stock 8,400 6.03 50.6K 5,271,378
2022-12-29 South Cone Investments Limited Partnership Director P-Purchase A Class A Common Stock 8,600 5.97 51.3K 6,706,054
2022-12-28 South Cone Investments Limited Partnership Director P-Purchase A Class A Common Stock 9,157 5.58 51.1K 6,697,454
2022-12-19 South Cone Investments Limited Partnership Director P-Purchase A Class A Common Stock 6,900 7.43 51.3K 6,688,297
2022-12-16 South Cone Investments Limited Partnership Director P-Purchase A Class A Common Stock 6,400 7.76 49.7K 6,681,397
2022-12-15 South Cone Investments Limited Partnership Director P-Purchase A Class A Common Stock 6,500 7.95 51.7K 6,674,997
2022-12-14 South Cone Investments Limited Partnership Director P-Purchase A Class A Common Stock 7,027 8.01 56.3K 6,668,497
2022-12-13 South Cone Investments Limited Partnership Director P-Purchase A Class A Common Stock 12,050 8.21 99.0K 6,658,678
2022-12-12 South Cone Investments Limited Partnership Director P-Purchase A Class A Common Stock 12,500 8.04 100.5K 6,646,628
2022-12-09 South Cone Investments Limited Partnership Director P-Purchase A Class A Common Stock 12,345 8.01 98.9K 6,634,128
2022-12-08 South Cone Investments Limited Partnership Director P-Purchase A Class A Common Stock 12,195 7.93 96.8K 6,621,783
2022-12-07 South Cone Investments Limited Partnership Director P-Purchase A Class A Common Stock 600 7.94 4.8K 6,609,588
2022-12-06 South Cone Investments Limited Partnership Director P-Purchase A Class A Common Stock 12,500 7.45 93.1K 6,608,988
2022-12-05 South Cone Investments Limited Partnership Director P-Purchase A Class A Common Stock 12,195 7.97 97.2K 6,596,488
2022-12-02 South Cone Investments Limited Partnership Director P-Purchase A Class A Common Stock 9,819 8.16 80.1K 6,584,293
2022-12-01 South Cone Investments Limited Partnership Director P-Purchase A Class A Common Stock 202 8.00 1.6K 6,574,474
2022-11-30 South Cone Investments Limited Partnership Director P-Purchase A Class A Common Stock 8,000 7.93 63.4K 6,574,272
2022-11-28 South Cone Investments Limited Partnership Director P-Purchase A Class A Common Stock 3,720 7.95 29.6K 6,566,272
2022-11-25 South Cone Investments Limited Partnership Director P-Purchase A Class A Common Stock 800 7.84 6.3K 6,562,552
2022-11-23 South Cone Investments Limited Partnership Director P-Purchase A Class A Common Stock 3,396 7.84 26.6K 6,561,752
2022-11-22 South Cone Investments Limited Partnership Director P-Purchase A Class A Common Stock 12,500 7.32 91.5K 6,558,356
2022-11-21 South Cone Investments Limited Partnership Director P-Purchase A Class A Common Stock 3,200 7.87 25.2K 6,545,856
2022-11-18 South Cone Investments Limited Partnership Director P-Purchase A Class A Common Stock 13,300 7.49 99.7K 6,542,656
2022-11-03 Quiroga Cortes Isidoro Alfonso Director P-Purchase A Class A Common Stock 15,192 6.90 104.8K 5,262,978
2022-11-02 Quiroga Cortes Isidoro Alfonso Director P-Purchase A Class A Common Stock 25,197 6.31 159.0K 5,247,786
2022-11-01 Quiroga Cortes Isidoro Alfonso Director P-Purchase A Class A Common Stock 3,768 5.98 22.5K 5,222,589
2022-10-31 Quiroga Cortes Isidoro Alfonso Director P-Purchase A Class A Common Stock 16,523 6.11 101.0K 5,218,821
2022-09-09 Sanford Svai S Officer F-InKind D Class A Common Stock 18,362 9.89 181.6K 120,738
2022-09-09 Hashim Mir Officer F-InKind D Class A Common Stock 20,334 9.89 201.1K 138,466
2022-08-23 IMRAN MIR A Director C-Conversion A Class A Common Stock 7,694 0.00 74,139
2022-08-23 Farquharson Andrew Director C-Conversion A Class A Common Stock 7,694 0.00 72,818
2022-08-17 IMRAN MIR A Director S-Sale D Class A Common Stock 9,210 11.62 107.0K 66,445
2022-08-17 Farquharson Andrew Director S-Sale D Class A Common Stock 71,042 10.51 746.7K 74,334
2022-05-25 Rometty Lisa Ann Director A-Award A Stock Option (Right to Buy) 16,112 0.00 16,112
2022-05-25 Nanavaty Maulik Director A-Award A Stock Option (Right to Buy) 41,416 0.00 41,416
2022-05-25 IMRAN MIR A Director A-Award A Stock Option (Right to Buy) 41,416 0.00 41,416
2022-05-25 Farquharson Andrew Director A-Award A Stock Option (Right to Buy) 41,416 0.00 41,416
2022-05-25 DEBUONO LAUREEN Director A-Award A Stock Option (Right to Buy) 41,416 0.00 41,416
2022-05-25 Baranowski Lyn Director A-Award A Stock Option (Right to Buy) 22,240 0.00 22,240
2022-05-25 BUTEL JEAN LUC Director A-Award A Stock Option (Right to Buy) 41,416 0.00 41,416
2022-05-25 Ausiello Dennis A Director A-Award A Stock Option (Right to Buy) 41,416 0.00 41,416
2022-03-22 Sanford Svai S Officer A-Award A Stock Option (Right to Buy) 100,000 0.00 100,000
2022-03-22 Imran Talat Officer A-Award A Class A Common Stock 86,600 0.00 98,943
2022-03-22 Hashim Mir Officer A-Award A Class A Common Stock 41,200 0.00 158,800
2022-03-22 Groen Eric Officer D Stock Option (Right to Buy) 130,000 11.00 1.43M 0
2022-03-07 IMRAN MIR A Director C-Conversion A Class A Common Stock 2,309,490 0.00 2,377,197
2022-03-07 Farquharson Andrew Director C-Conversion D Class A Common LLC Units 2,309,490 0.00 256,623
2022-02-03 Nanavaty Maulik Director J-Other A Class A Common Stock 11,017 0.00 11,017
2022-02-03 InCube Labs, L.L.C. 10% Owner J-Other A Class A Common Stock 13,923 0.00 13,923
2022-02-03 Imran Talat Director / Officer J-Other D Class A Common Stock 827,467 0.00 0
2022-02-03 IMRAN MIR A Director J-Other D Class A Common Stock 827,467 0.00 0
2022-02-03 Farquharson Andrew Director J-Other D Class A Common Stock 827,467 0.00 0
2022-01-03 Rometty Lisa Ann Director A-Award A Stock Option (Right to Buy) 49,037 17.00 833.6K 49,037
2021-11-10 Baranowski Lyn Director A-Award A Stock Option (Right to Buy) 31,695 26.78 848.8K 31,695
2021-09-09 Sanford Svai S Officer A-Award A Class A Common Stock 106,200 0.00 106,200
2021-09-09 Imran Talat Director / Officer A-Award A Stock Option (Right to Buy) 725,000 19.56 14.18M 725,000
2021-09-09 Hashim Mir Officer A-Award A Class A Common Stock 117,600 0.00 117,600
2021-08-03 Quiroga Moreno Isidoro 10% Owner P-Purchase A Class A Common Stock 2,727,273 11.00 30.00M 8,158,927
2021-07-30 Quiroga Moreno Isidoro 10% Owner P-Purchase A Class A Common Stock 158,904 11.25 1.79M 5,431,654
2021-07-29 Sanford Svai S Officer D Class A Common LLC Units 221,408 0.00 0
2021-07-29 Quiroga Moreno Isidoro 10% Owner I Class A Common Stock 0 0.00 4,000,510
2021-07-29 Nanavaty Maulik Director D Class B Common Stock 0 0.00 71,480
2021-07-29 InCube Labs, L.L.C. 10% Owner D Class B Common Stock 0 0.00 30,295,093
2021-07-29 Imran Talat Director / Officer D Stock Option (Right to Buy) 78,877 9.45 745.4K 0
2021-07-29 IMRAN MIR A Director I Class B Common Stock 0 0.00 33,765,518
2021-07-29 Hashim Mir Officer D Class B Common Stock 0 0.00 232,707
2021-07-29 Farquharson Andrew Director I Class A Common Stock 0 0.00 1,122,283
2021-07-29 DEBUONO LAUREEN Director D Stock Option (Right to Buy) 183,703 6.99 1.28M 0
2021-07-29 BUTEL JEAN LUC Director D Stock Option (Right to Buy) 183,703 6.99 1.28M 0
2021-07-29 Ausiello Dennis A Director D Class A Common LLC Units 143,229 0.00 0

Executive team

Top executives
EBIT / Employee
-3.6K
Shares Outstanding
65.32M

Executive compensation

Executive compensation (annual)
# Year Executive Salary Bonus Stock award Option award Incentive Other Total % Stock-
based
Filing
1 2025 Talat Imran Chief Executive Officer 198.3K 502.2K 351.6K 1.05M 47.73%
2 2025 Svai Sanford Chief Financial Officer 392.7K 139.0K 155.0K 259.7K 946.4K 16.38%
3 2025 Kate McKinley Chief Business Officer 370.5K 130.0K 201.6K 241.9K 943.9K 21.35%
4 2024 Talat Imran Chief Executive Officer 105.8K 2.94M 3.04M 96.52%
5 2024 Mir Hashim Chief Scientific Officer 416.0K 875.5K 1.29M 67.79%
6 2024 Svai Sanford Chief Financial Officer 416.0K 875.5K 1.29M 67.79%
7 2024 Kate McKinley Chief Business Officer 390.0K 875.5K 1.27M 69.18%
8 2023 Talat Imran Chief Executive Officer 450.0K 1.92M 2.89M 5.27M 91.46%
9 2023 Mir Hashim Chief Scientific Officer 416.0K 756.2K 996.2K 2.17M 80.81%
10 2023 Svai Sanford Chief Financial Officer 416.0K 756.2K 983.8K 2.16M 80.70%
11 2022 Talat Imran Chief Executive Officer 515.0K 1.14M 2.34M 312.0K 4.31M 80.82%
12 2022 Mir Hashim Chief Scientific Officer 412.0K 544.3K 1.11M 249.6K 2.32M 71.48%
13 2022 Svai Sanford Chief Financial Officer 412.0K 434.6K 888.5K 249.6K 1.98M 66.66%
14 2021 Talat Imran Chief Executive Officer 408.3K 11.00M 375.0K 11.78M 93.35%
15 2021 Mir Hashim Chief Scientific Officer 396.9K 2.30M 2.01M 300.0K 5.01M 86.08%
16 2021 Svai Sanford Chief Financial Officer 375.7K 2.08M 1.92M 300.0K 4.67M 85.54%
17 2021 Mir Imran Chairman and former President and Chief Executive Officer 33.3K 33.3K 0.00%
18 2020 Mir Hashim Chief Scientific Officer 325.5K 144.8K 160.0K 630.3K 22.97%
19 2020 Svai Sanford Chief Financial Officer 302.6K 77.2K 140.0K 519.8K 14.85%
20 2020 Mir Imran Chairman and former President and Chief Executive Officer
CEO compensation breakdown

Proxy statements

Proxy statements (DEF 14A)
Filing date Form type Filing
2026-04-16 DEFA14A
2026-04-16 DEF 14A
2025-04-30 DEFA14A
2025-04-16 DEFA14A
2025-04-16 DEF 14A

Recent SEC filings

Recent SEC filings
Filing date Form type Filing
2026-04-30 SC 13G
2026-04-16 DEFA14A
2026-04-16 DEF 14A
2026-04-16 ARS
2026-03-27 SC 13G/A
2026-03-27 3
2026-03-26 S-8
2026-03-26 8-K
2026-03-26 10-K
2026-02-13 SC 13G

Executive team

NameTitleCompensationGender
Svai S. Sanford Chief Financial Officer 791.4K male
Kate McKinley Chief Business Officer 742.4K female
Talat Imran Chief Executive Officer & Director 549.9K male
Mir Hashim Chief Scientific Officer 416.0K
Mir A. Imran Executive Chairman 30.0K male
Jesper Hoeiland Head of Strategy male
Bella Vazquez Senior Vice President of People & Administrative Services female
Arvinder Dhalla Vice President of Clinical Development female
Alireza Javadi Chief Technical Officer male
ESG Rating
B
BIOTECHNOLOGY
Rank: 488 out of 662
2025
E (Environmental)
56.1 / 56.3
Company / Sector avg.
S (Social)
65.6 / 62.4
Company / Sector avg.
G (Governance)
57.7 / 60.9
Company / Sector avg.
ESG Total
59.8 / 59.9
Company / Sector avg.
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits